Is it worth it to personalize the treatment of PTSD? - A variance-ratio meta-analysis and estimation of treatment effect heterogeneity in RCTs of PTSD.


Journal article


P. Herzog, Tim Kaiser
Journal of Anxiety Disorders, 2022

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Herzog, P., & Kaiser, T. (2022). Is it worth it to personalize the treatment of PTSD? - A variance-ratio meta-analysis and estimation of treatment effect heterogeneity in RCTs of PTSD. Journal of Anxiety Disorders.


Chicago/Turabian   Click to copy
Herzog, P., and Tim Kaiser. “Is It Worth It to Personalize the Treatment of PTSD? - A Variance-Ratio Meta-Analysis and Estimation of Treatment Effect Heterogeneity in RCTs of PTSD.” Journal of Anxiety Disorders (2022).


MLA   Click to copy
Herzog, P., and Tim Kaiser. “Is It Worth It to Personalize the Treatment of PTSD? - A Variance-Ratio Meta-Analysis and Estimation of Treatment Effect Heterogeneity in RCTs of PTSD.” Journal of Anxiety Disorders, 2022.


BibTeX   Click to copy

@article{p2022a,
  title = {Is it worth it to personalize the treatment of PTSD? - A variance-ratio meta-analysis and estimation of treatment effect heterogeneity in RCTs of PTSD.},
  year = {2022},
  journal = {Journal of Anxiety Disorders},
  author = {Herzog, P. and Kaiser, Tim}
}

Abstract

Several evidence-based treatments for posttraumatic stress disorder (PTSD) are recommended by international guidelines (e.g., APA, NICE). While their average effects are in general high, non-response rates indicate differential treatment effects. Here, we used a large database of RCTs on psychotherapy for PTSD to determine a reliable estimate of this heterogeneity in treatment effects (HTE) by applying Bayesian variance ratio meta-analysis. In total, 66 studies with a total of 8803 patients were included in our study. HTE was found for all psychological treatments, with varying degrees of certainty, only slight differences between psychological treatments, and active control groups yielding a smaller variance ratio compared to waiting list control groups. Across all psychological treatment and control group types, the estimate for the intercept was 0.12, indicating a 12% higher variance of posttreatment values in the intervention groups after controlling for differences in treatment outcomes. This study is the first to determine the maximum increase in treatment effects of psychological treatments for PTSD by personalization. The results indicate that there is comparatively high heterogeneity in treatment effects across all psychological treatment and control groups, which in turn allow personalizing psychological treatments by using treatment selection approaches.





Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in